Publications
71
Citations
3,698
Est. group size
—
Recurring co-author estimate
Active years
53
Publishing since 1974
Ira Miller's work focuses on rare and difficult-to-diagnose tumors and blood disorders, including bone and soft-tissue cancers (like sarcomas and chondrosarcomas), lymphomas, and unusual immune or blood conditions such as Castleman disease. Much of this output takes the form of detailed case reports and case series describing unusual clinical presentations, diagnostic challenges, and treatment approaches, alongside some larger studies on tumor mechanisms and outcomes.
Publication output has been relatively steady over the last decade, rising from a few papers per year around 2017 to a peak of about 7-8 papers annually in 2020-2022, before settling to a more modest pace of 3-5 papers per year in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- First Reported Successful Use of Infliximab Maintenance Therapy for Dual Treatment of Crohn Disease and Idiopathic Retroperitoneal Fibrosis
ACG Case Reports Journal · 2025
- Pneumococcal Sepsis in a Patient with Asplenia and Hypogammaglobulinemia
New England Journal of Medicine · 2025
- Somatic mutation discovery in idiopathic multicentric castleman disease (iMCD) lymph node tissue identifies dysregulated intracellular calcium signaling as a potential disease mechanism and therapeutic target
Blood · 2025
- Characterizing the Transformation and Diagnosis of Atypical Lipomatous Tumor to Dedifferentiated Liposarcoma: Single Institutional Outcomes
Journal of Surgical Oncology · 2024
- Enormous myxoid/round cell liposarcoma: A case report
Rare Tumors · 2024
- A Challenging Diagnosis of HHV-8-Associated Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in a Young Man with Newly-Diagnosed HIV
American Journal of Case Reports · 2024
- An Unusual Case of Clear Cell Chondrosarcoma With Early Metastatic Recurrence
International Journal of Surgical Pathology · 2024
- Characterizing the transformation and diagnosis of atypical lipomatous tumors to dedifferentiated liposarcoma: Single-institutional outcomes.
Journal of Clinical Oncology · 2024
- Rare Dedifferentiated Periosteal Chondrosarcoma with 11-Year Metastatic Relapse: A Case Report
International Journal of Surgical Pathology · 2023
- Exploratory Analyses of Lymph Node Tissue, Serum, and Peripheral Blood Mononuclear Cells Do Not Reveal Pathogen Signatures in Idiopathic Multicentric Castleman Disease
Blood · 2023
- Author response for "Rare Dedifferentiated Periosteal Chondrosarcoma with 11-Year Metastatic Relapse: A Case Report"
2023
- Author response for "Rare Dedifferentiated Periosteal Chondrosarcoma with 11-Year Metastatic Relapse: A Case Report"
2023
- Dedifferentiated Chondrosarcoma: A Case Series and Review of the Literature
Orthopedic Reviews · 2022
- An Atypical Adverse Local Tissue Reaction After Ceramic-on-Ceramic Primary Total Hip Arthroplasty
Arthroplasty Today · 2022
- Neoadjuvant radiation influences the pseudocapsule in soft tissue sarcoma: A histopathologic and radiographic evaluation
Surgical Oncology · 2022
- Blood×4
- Journal of Surgical Oncology×3
- Blood Advances×3
- Orthopedic Reviews×2
- International Journal of Surgical Pathology×2
- Paul E. Wakely
Medicine · The Ohio State University
- Joel L. Mayerson
Medicine · The Ohio State University
- Joel Mayerson
Medicine · The Ohio State University
- Laura M. Warmke
Medicine · Indiana University
- Nathan D. Seligson
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile